10x, Curio Settle Genomics Patent Suit Before Trial
10x Genomics on Friday said it has agreed to end its suit accusing Curio Bioscience of infringing a series of Prognosys Biosciences genomics technology patents that 10x Genomics is licensed to...To view the full article, register now.
Already a subscriber? Click here to view full article